Takahashi T, Ishida K, Itoh K, Konishi Y, Yagyu K-I, Tominaga A, Miyazaki J-I, Yamamoto H
Department of Orthopaedic Surgery, Kochi Medical School, Nankoku, Japan.
Gene Ther. 2003 Apr;10(8):612-20. doi: 10.1038/sj.gt.3301900.
The goal of this study was to determine whether insulin-like growth factor-I (IGF-I) gene delivery by electroporation promotes repair after muscle injury. An injury-repair model was created using mice in which a hamstring muscle was cut and sutured. A total of 50 microg of IGF-I DNA or green fluorescent protein (GFP) DNA (both in pCAGGS) was injected into the lesion and introduced into muscle cells by electrostimulation using an electric pulse generator. The number of regenerating muscle fibers in the IGF-I DNA group was significantly more than that in the GFP DNA group at 2 weeks after injection. The diameter of regenerating muscle fibers from the IGF-I DNA group was larger than that of the GFP DNA group at 4 weeks after injection. There was no significant difference in the serum IGF-I concentration between the IGF-I DNA group and the GFP DNA group at 1, 2, and 4 weeks after injection. However, muscle IGF-I concentration in the IGF-I DNA injection group was significantly greater than that in the GFP DNA injection group at 2 weeks after injection. These results demonstrated that the effects of enhanced IGF-I production were local and limited to the injected area. The ratio (injected/uninjected; intact) of the amplitude of compound muscle action potentials (CMAP) in the IGF-I DNA injection group was greater than that in the GFP DNA injection group at 4 weeks after injection and of the control group. In conclusion, IGF-I gene transfer by electroporation proved to be a simple, safe, inexpensive, and effective method to promote the regeneration of injured muscles in our injury model.
本研究的目的是确定通过电穿孔进行胰岛素样生长因子-I(IGF-I)基因递送是否能促进肌肉损伤后的修复。使用小鼠建立损伤-修复模型,其中股二头肌被切断并缝合。将总共50微克的IGF-I DNA或绿色荧光蛋白(GFP)DNA(均在pCAGGS载体中)注射到损伤部位,并使用电脉冲发生器通过电刺激将其导入肌肉细胞。注射后2周,IGF-I DNA组中再生肌纤维的数量明显多于GFP DNA组。注射后4周,IGF-I DNA组再生肌纤维的直径大于GFP DNA组。注射后1、2和4周,IGF-I DNA组和GFP DNA组之间的血清IGF-I浓度无显著差异。然而,注射后2周,IGF-I DNA注射组的肌肉IGF-I浓度明显高于GFP DNA注射组。这些结果表明,IGF-I产生增强的作用是局部的,且仅限于注射区域。注射后4周,IGF-I DNA注射组复合肌肉动作电位(CMAP)幅度的比率(注射/未注射;完整)大于GFP DNA注射组和对照组。总之,在我们的损伤模型中,通过电穿孔进行IGF-I基因转移被证明是一种促进受伤肌肉再生的简单、安全、廉价且有效的方法。